New blood test diagnoses Alzheimer's disease

Digest more
Scientists Develop Blood Test That Diagnoses Alzheimer’s And Identifies What Stage It Has Reached
Scientists have developed a blood test for Alzheimer’s disease that can help diagnose the neurodegenerative disease while also indicating how far it has progressed. The results could help doctors decide which medications to prescribe depending on how long they’ve had the condition.
New blood test diagnoses Alzheimer’s disease and measures how far it's progressed
A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another condition is causing a person’s cognitive symptoms.
New study identifies a blood test to diagnose and assess severity of Alzheimer's
Researchers from Washington University School of Medicine and Lund University have identified a highly accurate blood test that can both diagnose and asses

Lowering LDL 'bad' cholesterol can reduce dementia risk

Digest more
Blood test can predict dementia risk up to 10 years in advance, study shows
Researchers at Karolinska Institutet have demonstrated how specific biomarkers in the blood can predict the development of dementia up to 10 years before diagnosis, among older adults living independently in the community.
Statins could reduce dementia risk even if you have low cholesterol
While statins are mainly known for lowering cholesterol, research suggests they might also reduce the risk of dementia
Tackling bad cholesterol levels with statins may reduce dementia risk
Statins are commonly prescribed to help cut the chance of heart attack and stroke. Now new research suggests they may have more benefits.Experts found that people who have low levels of "bad" cholesterol in their blood have a reduced risk of dementia,
Mirage News15h
Blood Test May Rule Out Future Dementia Risk
Researchers at Karolinska Institutet have demonstrated how specific biomarkers in the blood can predict the development of ...
KALW5h
Latest Alzheimer's lab tests focus on memory loss, not brain plaques
Worley was part of a team that showed how the loss of one of the two proteins used in the test disrupts synapses and leads to ...